Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
Use this DNLI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DNLI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DNLI SEC filings page. Lician reads the product cache first so this HTML stays unique to Denali Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full DNLI income, balance, and cash tables.